Research & Literature

C1q nephropathy in India: a single-center study.

Kanodia KV, Vanikar AV, Patel RD, et al.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2015; (26(2)):398-403 doi:10.4103/1319-2442.152562.

Resolution of C1q deposition but not of the clinical nephrotic syndrome after immunomodulating therapy in focal sclerosis.

Tibor Fülöp T, Csongrádi É, Lerant AA, et al.

Journal of nephropathology 2015; (4(2)):54-8 doi:10.12860/jnp.2015.11.

A clinicopathological study of C1q nephropathy at King Abdulaziz University.

Mokhtar GA, Jalalah SM

Iranian journal of kidney diseases 2015; (9(4)):279-85.

AKI in Children Hospitalized with Nephrotic Syndrome.

Rheault MN, Zhang L, Selewski DT, et al.

Clinical journal of the American Society of Nephrology : CJASN 2015; (10(12)):2110-8 doi:10.2215/CJN.06620615.

Albumin and Furosemide Combination for Management of Edema in Nephrotic Syndrome: A Review of Clinical Studies.

Duffy M, Jain S, Harrell N, et al.

Cells 2015; (4(4)):622-30 doi:10.3390/cells4040622.

C1q Nephropathy: The Unique Underrecognized Pathological Entity.

Devasahayam J, Erode-Singaravelu G, Bhat Z, et al.

Analytical cellular pathology (Amsterdam) 2015; (2015()):490413 doi:10.1155/2015/490413.

[C1Q NEPHROPATHY: CASE REPORTS AND LITERATURE REVIEW].

Galešić K, Horvatić I, Batinić D, et al.

Lijecnicki vjesnik 2015; (137(9-10)):283-7.

Pathophysiology, Evaluation, and Management of Edema in Childhood Nephrotic Syndrome.

Ellis D

Frontiers in pediatrics 2015; (3()):111 doi:10.3389/fped.2015.00111.

Diuretic Resistance.

Hoorn EJ, Ellison DH

American journal of kidney diseases : the official journal of the National Kidney Foundation 2017; (69(1)):136-142 doi:10.1053/j.ajkd.2016.08.027.

[Advances in clinical research on C1q nephropathy].

Yang J, Zhang BL

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2016; (18(11)):1194-1198.

Nephrotoxicity in children with frequently relapsing nephrotic syndrome receiving long-term cyclosporine treatment.

Hamasaki Y, Komaki F, Ishikura K, et al.

Pediatric nephrology (Berlin, Germany) 2017; (32(8)):1383-1390 doi:10.1007/s00467-017-3641-4.

[Idiopathic nephrotic syndrome (INS) in children in Dakar: about 40 cases].

Keita Y, Lemrabott AT, Sylla A, et al.

The Pan African medical journal 2017; (26()):161 doi:10.11604/pamj.2017.26.161.10130.

Nephrotic syndrome in infants and children: pathophysiology and management.

Downie ML, Gallibois C, Parekh RS, Noone DG

Paediatrics and international child health 2017; (37(4)):248-258 doi:10.1080/20469047.2017.1374003.

Diagnosis and management of nephrotic syndrome.

McCloskey O, Maxwell AP

The Practitioner 2017; (261(1801)):11-5.

Urinary potassium to urinary potassium plus sodium ratio can accurately identify hypovolemia in nephrotic syndrome: a provisional study.

Keenswijk W, Ilias MI, Raes A, et al.

European journal of pediatrics 2018; (177(1)):79-84 doi:10.1007/s00431-017-3029-2.

Glucocorticoids in the Treatment of Glomerular Diseases: Pitfalls and Pearls.

Ponticelli C, Locatelli F

Clinical journal of the American Society of Nephrology : CJASN 2018; (13(5)):815-822 doi:10.2215/CJN.12991117.

Predominant but silent C1q deposits in mesangium on transplanted kidneys - long-term observational study.

Kanai T, Akioka Y, Miura K, et al.

BMC nephrology 2018; (19(1)):82 doi:10.1186/s12882-018-0874-9.

Acute kidney injury complicating nephrotic syndrome of minimal change disease.

Meyrier A, Niaudet P

Kidney international 2018; (94(5)):861-869 doi:10.1016/j.kint.2018.04.024.

C1q Nephropathy in a Patient of Neurofibromatosis Type 1: A Rare Case Report.

Varyani UT, Shah NM, Shah PR, et al.

Indian journal of nephrology 2019; (29(2)):125-127 doi:10.4103/ijn.IJN_353_17.

C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics.

Kim K, Son HE, Ryu JY, et al.

PloS one 2019; (14(4)):e0215217 doi:10.1371/journal.pone.0215217.

C1Q Nephropathy: A Multifaceted Disease With Infrequent Diagnosis.

Tariq N, Nasir H, Ahmed TA, et al.

Journal of Ayub Medical College, Abbottabad : JAMC 2019; (31(3)):308-313.

Steroid-Associated Side Effects in Patients With Primary Proteinuric Kidney Disease.

Oh GJ, Waldo A, Paez-Cruz F, et al.

Kidney international reports 2019; (4(11)):1608-1616 doi:10.1016/j.ekir.2019.08.019.

C1q nephropathy developing in a case of gastric carcinoma.

Malhotra KP, Chandra A, Shukla S, et al.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2019; (30(6)):1457-1460 doi:10.4103/1319-2442.275493.

Infections in Children With Nephrotic Syndrome: Twenty Years of Experience.

Lebel A, Kropach N, Ashkenazi-Hoffnung L, et al.

Clinical pediatrics 2020; (59(7)):692-698 doi:10.1177/0009922820908583.

Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).

Yamamoto R, Imai E, Maruyama S, et al.

Clinical and experimental nephrology 2020; (24(6)):526-540 doi:10.1007/s10157-020-01864-1.

[Vaccine recommendations for children with idiopathic nephrotic syndrome].

Boyer O, Baudouin V, Bérard É, et al.

Nephrologie & therapeutique 2020; (16(3)):177-183 doi:10.1016/j.nephro.2019.09.007.

Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease.

Weaver DJ, Waldo A, Oh GJ, et al.

Kidney medicine 2020; (2(2)):131-138 doi:10.1016/j.xkme.2019.10.012.

Oxidative stress markers in initial therapy and remission of nephrotic syndrome and serum malondialdehyde level predictor from routine laboratory test.

Habriel Ruslie R, Rina Ramayani O, Darmadi D, Alamsyah Siregar G

Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina 2021; (18(1)):90-95 doi:10.17392/1192-21.

Mechanisms and management of edema in pediatric nephrotic syndrome.

Kallash M, Mahan JD

Pediatric nephrology (Berlin, Germany) 2021; (36(7)):1719-1730 doi:10.1007/s00467-020-04779-x.

[C1q nephropathy. Report of one case].

Vega J, Gutiérrez E, Méndez GP, Bofill L

Revista medica de Chile 2020; (148(5)):702-706 doi:10.4067/S0034-98872020000500702.

Pediatric Nephrotic Syndrome: Pharmacologic and Nutrition Management.

Hampson KJ, Gay ML, Band ME

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2021; (36(2)):331-343 doi:10.1002/ncp.10622.

Case Report: Complete Remission of C1q Nephropathy Treated With a Single Low-Dose Rituximab, a Reality or Coincidence?

Ma R, Wu D, He Z, et al.

Frontiers in pediatrics 2020; (8()):568773 doi:10.3389/fped.2020.568773.

Clinicopathological Pattern of Non-lupus Full House Nephropathy.

Wani AS, Zahir Z, Gupta A, Agrawal V

Indian journal of nephrology 2020; (30(5)):301-306 doi:10.4103/ijn.IJN_91_18.

Acute myocardial infarction in a child with nephrotic syndrome.

Charfeddine S, Yousfi C, Maalej B, et al.

Revista portuguesa de cardiologia 2021; (40(6)):457.e1-457.e4 doi:10.1016/j.repce.2021.07.011.

Risk of Arterial Thromboembolism, Venous Thromboembolism, and Bleeding in Patients with Nephrotic Syndrome: A Population-Based Cohort Study.

Vestergaard SV, Birn H, Darvalics B, et al.

The American journal of medicine 2022; (135(5)):615-625.e9 doi:10.1016/j.amjmed.2021.11.018.

C1q Nephropathy in Children with Nephrotic Syndrome: Treatment Strategies and Outcomes.

Gaur S, Patrick R, Vankalakunti M, Phadke K

Indian journal of nephrology 2022; (32(1)):54-59 doi:10.4103/ijn.IJN_578_20.

The appearance of C1q deposition in transplanted kidney allografts and its clinical and histopathologic features.

Jo EA, Kim HK, Min S, et al.

Korean journal of transplantation 2022; (36(3)):180-186 doi:10.4285/kjt.22.0032.

The challenges of the pandemic and the vaccination against covid-19 in pediatric patients with kidney disease.

Soeiro EMD, Penido MGMG, Palma LMP, et al.

Jornal brasileiro de nefrologia 2023; (45(2)):244-251 doi:10.1590/2175-8239-JBN-2022-0081en.

Vaccines and nephrotic syndrome: efficacy and safety.

Angeletti A, Lugani F, La Porta E, et al.

Pediatric nephrology (Berlin, Germany) 2023; (38(9)):2915-2928 doi:10.1007/s00467-022-05835-4.

Subclinical C1q Nephropathy Combined with Possible Donor-Derived IgA Deposition in a 1-Year Kidney Allograft Biopsy: A Case Report.

Kounoue N, Oguchi H, Hamasaki Y, et al.

Transplantation proceedings 2023; (55(4)):1084-1088 doi:10.1016/j.transproceed.2023.03.024.

A clinicopathological and prognostic study of 18 children with C1q nephropathy and focal segmental glomerulosclerosis: an 18-year experience from a single center.

Peng Y, Ju T, Gao C, et al.

Journal of nephrology 2023; (36(6)):1615-1625 doi:10.1007/s40620-023-01679-9.

Nephrotic syndrome: pathophysiology and consequences.

Ponticelli C, Moroni G

Journal of nephrology 2023; (36(8)):2179-2190 doi:10.1007/s40620-023-01697-7.

Thromboembolism in nephrotic syndrome: controversies and uncertainties.

Parker K, Ragy O, Hamilton P, et al.

Research and practice in thrombosis and haemostasis 2023; (7(6)):102162 doi:10.1016/j.rpth.2023.102162.

Pediatric Bilateral Hypoplastic Kidney Complicated With C1q Nephropathy: A Case Report.

Kanai H, Sawanobori E, Kobayashi A, Goto M

Cureus 2024; (16(7)):e63923 doi:10.7759/cureus.63923.

Nephrotic Syndrome Without Nephrotic Range Proteinuria.

Sheikh JA, Syed U, Osama SM

Cureus 2024; (16(7)):e64342 doi:10.7759/cureus.64342.

Endocrine Disorders in Nephrotic Syndrome-A Comprehensive Review.

Mizdrak M, Smajic B, Mizdrak I, et al.

Biomedicines 2024; (12(8)) doi:10.3390/biomedicines12081860.

Drug-drug interaction between diltiazem and tacrolimus in relation to CYP3A5 genotype status in Chinese pediatric patients with nephrotic range proteinuria: a retrospective study.

Yang Q, Wang Y, Wang X, et al.

Frontiers in pharmacology 2024; (15()):1463595 doi:10.3389/fphar.2024.1463595.

Characteristics of glomerulonephritis with dominant C1q precipitation compared to corresponding glomerulonephritis without C1q staining on immunofluorescent examination.

Ryu JY, Yun G, Kwon EJ, et al.

Kidney research and clinical practice 2025; (44(4)):638-650 doi:10.23876/j.krcp.23.238.

Isolated superior mesenteric vein thrombosis in an adult with nephrotic syndrome due to minimal change disease: a case report.

Dakak AG, Mahgoub MK, Jalkhi TA, et al.

Journal of medical case reports 2025; (19(1)):149 doi:10.1186/s13256-025-05130-4.

Post-varicella vaccination uveitis in a child with nephrotic syndrome receiving immunosuppressive treatment: a case report.

Andrade C, de Almeida Cordeiro M, Baeta Baptista R, et al.

Frontiers in pediatrics 2025; (13()):1567164 doi:10.3389/fped.2025.1567164.

Prophylactic anticoagulation in patients with nephrotic syndrome in the Cure Glomerulonephropathy (CureGN) cohort.

Tarragón B, Han H, Navarro-Torres M, et al.

Clinical kidney journal 2025; (18(5)):sfaf104 doi:10.1093/ckj/sfaf104.

Prescribing Inflammatory Bowel Disease Medications in Chronic Kidney Disease: A Practical Guide.

Chen L, Srinivasan A, Choy SW, et al.

Alimentary pharmacology & therapeutics 2025; (62(4)):400-418 doi:10.1111/apt.70262.

A Mycophenolic Acid Concentration-Time Curve (0-12 Hours) to Maintain Remission Without Recurrent Infection in C1q Nephropathy: A Case Report.

Ishii M, Kanai T, Aoyagi J, et al.

Cureus 2025; (17(7)):e87544 doi:10.7759/cureus.87544.

Hepatic tuberculosis induced by rituximab treatment for C1q nephropathy with minimal change disease: a case report.

Wang H, Huang Y, Jin F, Liu X

Frontiers in medicine 2025; (12()):1621723 doi:10.3389/fmed.2025.1621723.

Steroid-Dependent Nephrotic Syndrome With Remission After Rituximab Implementation in a 14-Year-Old Boy: A Case Report.

Waska G, Pielorz-Janiczek K, Badeński A, et al.

Cureus 2025; (17(9)):e91845 doi:10.7759/cureus.91845.

Predictors of time to remission in children with steroid-sensitive nephrotic syndrome: a prospective observational study in Nepal.

Baral R, Bhatta M, Khan SA, et al.

BMC nephrology 2025; (27(1)):77 doi:10.1186/s12882-025-04699-8.

Managing concurrent nephrotic syndrome, spontaneous bacterial peritonitis, and herpes zoster in an immunocompromised child: Diagnostic difficulties and treatment outcomes.

Adrizain R, Modjaningrat I, Winyarti , et al.

IDCases 2026; (43()):e02489 doi:10.1016/j.idcr.2026.e02489.

Rapid renal salvage in acute renal vein thrombosis secondary to membranous nephropathy using large-bore mechanical thrombectomy.

Singh SD, Gan CC, Lee L, et al.

Thrombosis journal 2026; (24(1)).

Fulminant campylobacter jejuni bacteremia complicating steroid-dependent nephrotic syndrome in a pediatric patient: a case report.

Elmezayen ZW, Adi M, Albaroudi FH, Elmezayen RW

BMC infectious diseases 2026; (26(1)).

Unprovoked Pulmonary Embolism with Bilateral Deep Vein Thrombosis Revealing Occult Nephrotic Syndrome Due to Seronegative Membranous Nephropathy.

Eser S, Serra A, Kleber M, Brombacher F

European journal of case reports in internal medicine 2026; (13(4)):006359 doi:10.12890/2026_006359.

Purtscher-like retinopathy presenting as acute vision loss in childhood nephrotic syndrome: case report with review of literature.

Sadasivam D, Singh SR, Poojary S, et al.

CEN case reports 2026; (15(4)).

Outcome of children treated with rituximab for steroid-resistant nephrotic syndrome: Renal histopathology as a response marker.

Alsalloum AA, Farhat AH, Al-Herbish A, et al.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2026; (37(3)):168-175 doi:10.4103/sjkdt.sjkdt_10_26.